ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

Insiders Signal Conviction With Fresh Filings

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Silver Lake's massive DELL exit dominates this week's insider activity. The investment firm filed this week disclosing it sold over $120 million worth of Dell Technologies shares across multiple transactions between June 2–4. Prices ranged from $414 to $435 per share. The selling is relentless — six separate filings hit in four days.

Meanwhile, NVDA director Mark Stevens filed disclosures showing he sold $199 million in Nvidia stock on June 2–4. Two tranches — 500,000 shares at $222 and 400,000 at $220 — signal the long-time board member is cashing out near all-time highs.

On the buying side, the story is more encouraging. NSP CEO Paul Sarvadi filed a $7.9 million personal purchase on June 3. That's 233,000 shares at $34.05. A CEO buying nearly $8M of their own company is a strong vote of confidence.

Robinhood director Meyer Malka also filed this week. He bought $20.2 million in HOOD shares on June 5 through Ribbit Capital — the venture firm he leads. It's the biggest director purchase of the week in the US.

SMMT CEO Maky Zanganeh bought $1.46 million in Summit Therapeutics stock on June 4, the same day the filing hit. Fresh CEO buying in a biotech is always worth watching.

RYAN founder Patrick Ryan filed a $3.9 million purchase on June 5. The executive chairman of Ryan Specialty added 120,000 shares at roughly $32.50 each.

This is not financial advice.

Stocks in this article

How this article was generated

Generated
11 Jun 2026, 12:11
Prompt version
v1.0
Data sources
Institutional positioning

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.